| EXPORT
ACTTIVITIES
Exports represent a crucial
and strategic importance for the company to avoid the imposed profit
margin caps and are nsubjected to government regulation, due to the
low cost base; Egyptian drugs are considered price competitive when
exports abroad.
EIPICO started focusing on
export activities two years after it commenced operation. Currently
the company exports for L.E. 800 000 (US$ 0.24 million) or 1.8% to
total sales in 1987 to LE 51 million (US$ 15 million) or 15.7% of
total sales in 1998.
At the end of 1998, total
exports amounted 15.7% of total sales mainly sold to countries of
East Europe, Arab, Asian and African countries. Our strategy is to
increase this share to reach 25-30% of EIPICO products (excluding
under license) by the start of 2001 to meet the needs for
importation and to hedge against foreign currency fluctuations.
Now EIPICO exports around
190 products and further registration of products is taking place in
the same markets and other countries for future activities.
EIPICO is now reputed in
all markets for the quality of its products with competitive and
attractive prices and is managing to penetrate other export markets | 
Home
